Get started
Author

Karin Kosulin

Observed names: K Kosulin, K. Kosulin, Kosulin Karin, Kosulin, Karin
Institution: Valneva (Austria)
ORCID: 0000-0001-7397-9692
Observed ORCID: 0000-0001-7397-9692
OpenAlex ID: A5065082463
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
2023 · Martina Schneider, Marivic Narciso-Abraham, et al. · The Lancet · 255
PDF
Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation
2010 · T Lion, K Kosulin, et al. · Leukemia · 202
Persistence and reactivation of human adenoviruses in the gastrointestinal tract
2015 · K. Kosulin, E. Geiger, et al. · Clinical Microbiology and Infection · 164
PDF
Management of adenovirus infection in patients after haematopoietic stem cell transplantation: State‐of‐the‐art and real‐life current approach
2018 · Prashant Hiwarkar, Karin Kosulin, et al. · Reviews in Medical Virology · 99
Investigation of Adenovirus Occurrence in Pediatric Tumor Entities
2007 · Karin Kosulin, Christine Haberler, et al. · Journal of Virology · 63
Polylactic acid as a suitable material for 3D printing of protective masks in times of COVID-19 pandemic
2020 · Eva Vaňková, Petra Kašparová, et al. · PeerJ · 54
Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study
2024 · Robert McMahon, Sebastian Toepfer, et al. · The Lancet Infectious Diseases · 52
Intestinal HAdV Infection: Tissue Specificity, Persistence, and Implications for Antiviral Therapy
2019 · Karin Kosulin · Viruses · 49
PDF
Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis
2013 · Manfred Marschall, Ina Niemann, et al. · Antiviral Research · 48
Intestinal Adenovirus Shedding Before Allogeneic Stem Cell Transplantation Is a Risk Factor for Invasive Infection Post-transplant
2018 · Karin Kosulin, Bettina Berkowitsch, et al. · EBioMedicine · 47
PDF
Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples
2017 · Jakob Thannesberger, Hans-Joerg Hellinger, et al. · The FASEB Journal · 47
Post-transplant Replication of Torque Teno Virus in Granulocytes
2018 · Karin Kosulin, Silvia Kernbichler, et al. · Frontiers in Microbiology · 40
PDF
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection
2024 · Whitney C. Weber, Zachary J. Streblow, et al. · Vaccines · 39
PDF
A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults
2023 · Robert McMahon, Ulrike Fuchs, et al. · Journal of Travel Medicine · 38
PDF
R-(+)-α-lipoic acid inhibits endothelial cell apoptosis and proliferation: involvement of Akt and retinoblastoma protein/E2F-1
2007 · Michaela Artwohl, Kathrin Muth, et al. · American Journal of Physiology-Endocrinology and Metabolism · 37
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents
2024 · Vera Buerger, Sandra Hadl, et al. · The Lancet Infectious Diseases · 33
Human cytomegalovirus infection downregulates vitamin-D receptor in mammalian cells
2016 · Franz J.J. Rieder, Charlotte Gröschel, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 31
Diagnostic Parameters of Adenoviremia in Pediatric Stem Cell Transplant Recipients
2019 · Karin Kosulin, Herbert Pichler, et al. · Frontiers in Microbiology · 22
PDF
Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages
2025 · Karin Kosulin, Trevor L. Brasel, et al. · Emerging Microbes & Infections · 15
Combined immunogenicity evaluation for a new single-dose live-attenuated chikungunya vaccine
2024 · Vera Buerger, Gabriele Maurer, et al. · Journal of Travel Medicine · 15
PDF
Presence of Adenovirus Species C in Infiltrating Lymphocytes of Human Sarcoma
2013 · Karin Kosulin, Franziska Hoffmann, et al. · PLoS ONE · 15
PDF
Modified pan-adenovirus real-time PCR assay based on genome analysis of seventy HAdV types
2016 · Karin Kosulin, Bettina Berkowitsch, et al. · Journal of Clinical Virology · 14
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil
2025 · Vera Buerger, Andrea Pfeiffer, et al. · The Lancet Infectious Diseases · 9
Screening for adenoviruses in haematological neoplasia: High prevalence in mantle cell lymphoma
2013 · Karin Kosulin, Margit Rauch, et al. · European Journal of Cancer · 8
Broad-Spectrum Antiviral Activity of the Deubiquitinase Inhibitor HBX against Human Adenoviruses
2017 · Karin Kosulin, Elena Lam, et al. · Antiviral Therapy · 7
Works count: 37
Citation count: 1,428
H-index: 18
I10-index: 22
Year
Topic
Type